LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4445 | 4203 | 1.0582 | 1.0640 |
MCF7 | Sigma A6730 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 2001 | 4203 | 0.4764 | 0.3230 |
MCF7 | WH-4-025 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3748 | 4203 | 0.8918 | 0.8764 |
MCF7 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3957 | 4203 | 0.9412 | 0.9334 |
MCF7 | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3723 | 4203 | 0.8869 | 0.8705 |
MCF7 | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2153 | 4203 | 0.5125 | 0.3779 |
MCF7 | HG-5-113-01 | 1.11 | uM | LJP5 | 72 | hr | 1209 | 1448 | 4203 | 0.3457 | 0.1064 |
MCF7 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1316 | 4203 | 0.3136 | 0.0480 |
MCF7 | HG-5-113-01 | 10 | uM | LJP5 | 72 | hr | 1209 | 569 | 4203 | 0.1358 | -0.3430 |
MCF7 | SB590885 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3687 | 4203 | 0.8774 | 0.8595 |
MCF7 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4412 | 4203 | 1.0522 | 1.0586 |
MCF7 | SB590885 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4099 | 4203 | 0.9746 | 0.9707 |
MCF7 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 4175 | 4203 | 0.9932 | 0.9920 |
MCF7 | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1209 | 3350 | 4203 | 0.7974 | 0.7628 |
MCF7 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4156 | 4203 | 0.9898 | 0.9893 |
MCF7 | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1390 | 4203 | 0.3315 | 0.0809 |
MCF7 | CP466722 | 1.11 | uM | LJP5 | 72 | hr | 1209 | 3824 | 4203 | 0.9113 | 0.8991 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 2258 | 4203 | 0.5386 | 0.4170 |
MCF7 | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 3332 | 4203 | 0.7963 | 0.7620 |
MCF7 | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 1209 | 1495 | 4203 | 0.3557 | 0.1241 |
MCF7 | CP466722 | 10 | uM | LJP5 | 72 | hr | 1209 | 1742 | 4203 | 0.4146 | 0.2244 |
MCF7 | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3690 | 4203 | 0.8761 | 0.8552 |
MCF7 | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3310 | 4203 | 0.7868 | 0.7488 |
MCF7 | PD184352 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2969 | 4203 | 0.7079 | 0.6502 |
MCF7 | PD184352 | 0.12 | uM | LJP5 | 72 | hr | 1209 | 3009 | 4203 | 0.7150 | 0.6576 |